Walking away from cancer fog: exercise boosts quality of life in survivors
NCT ID NCT06540612
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a 12-week aerobic exercise program can improve quality of life, thinking skills, and physical function in women who have finished breast cancer treatment. 69 survivors were split into three groups: one did moderate aerobic exercise three times a week, one got physical activity counseling, and one continued their normal routine. Researchers measured changes in blood markers, fitness, and well-being over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Aerobic exercise
- What this could lead to
- If it works, this could show that a simple exercise program helps breast cancer survivors feel better, think clearer, and have improved physical function.
- What could go wrong
- This is a small, completed study with no blinding or long-term follow-up. Results may not apply to all survivors, and exercise benefits can vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
69 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged between 18 and 65 * Literate * Diagnosed with stage 2 breast cancer * Completed primary breast cancer treatment at least 6 months ago (excluding hormone therapy/aromatase inhibitors) * Provided cooperation * Female * Patients who are willing and willing to participate in the study Exclusion Criteria: * Those who are using psychotic, anxiolytic, antidepressant, analgesic and sleeping pills * Those with metastasis * Those with a history of lymphedema * Those with neurological disease * Those who are pregnant or breastfeeding * Uncontrolled hypertensive patients * Those who are incapable of verbal communication or physical movement
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer female are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nahide FIDANCIOGLU
Yenimahalle, Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can watching your own brain activity on a screen sharpen memory after childhood brain cancer?
- Can an oral drug replace injections for advanced breast cancer?
- Can a tiny clip spare breast cancer patients full lymph node removal?
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?